U.S. markets closed
  • S&P 500

    4,026.12
    -1.14 (-0.03%)
     
  • Dow 30

    34,347.03
    +152.97 (+0.45%)
     
  • Nasdaq

    11,226.36
    -58.96 (-0.52%)
     
  • Russell 2000

    1,869.19
    +5.67 (+0.30%)
     
  • Crude Oil

    76.28
    -1.66 (-2.13%)
     
  • Gold

    1,754.00
    +8.40 (+0.48%)
     
  • Silver

    21.43
    +0.06 (+0.29%)
     
  • EUR/USD

    1.0405
    -0.0008 (-0.07%)
     
  • 10-Yr Bond

    3.6910
    -0.0150 (-0.40%)
     
  • GBP/USD

    1.2091
    -0.0023 (-0.19%)
     
  • USD/JPY

    139.1000
    +0.5100 (+0.37%)
     
  • BTC-USD

    16,462.78
    -45.49 (-0.28%)
     
  • CMC Crypto 200

    386.97
    +4.32 (+1.13%)
     
  • FTSE 100

    7,486.67
    +20.07 (+0.27%)
     
  • Nikkei 225

    28,283.03
    -100.06 (-0.35%)
     

CVS Health Expands Home Healthcare Portfolio With $8B Signify Health Acquisition

CVS Health Corp (NYSE: CVS) has agreed to acquire Signify Health Inc (NYSE: SGFY) for $30.50 per share in cash, representing a total transaction value of approximately $8 billion.

  • Signify Health offers Health Risk Assessments, value-based care, and provider enablement via a network of over 10,000 clinicians across all 50 states.

  • In 2022, Signify Health's clinicians expect to connect with nearly 2.5 million unique members in the home, both in-person and virtually. On average, they spend 2.5 times longer with a patient in the home than providers spend in the average primary care office visit.

  • Since acquiring Caravan Health in March, Signify Health has expanded its focus on value-based care and population health.

  • Following the close of the transaction, Kyle Armbrester will continue to lead Signify Health as part of CVS Health.

  • CVS Health expects to fund the transaction with existing cash from its balance sheet.

  • CVS Health and Signify Health anticipate that the transaction will close in the first half of 2023.

  • "We expect the acquisition to be meaningfully accretive to earnings and, as a result, are increasingly confident we can achieve our long-term adjusted EPS goals as outlined at our Investor Day in December 2021," said CVS Health EVP & CEO Shawn Guertin.

Price Action: CVS shares closed at $99.44 on Friday. SGFY shares are up 1.18% at $29.11 during the premarket session on the last check Tuesday.

Photo: Courtesy of Mike Mozart on flickr

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.